Disruption of spindle checkpoint function ahead of facilitation of cell proliferation by repeated administration of hepatocarcinogens in rats.

M. Kimura, S. Mizukami, Yousuke Watanabe, Yasuko Hasegawa-Baba, N. Onda, Toshinori Yoshida, M. Shibutani
{"title":"Disruption of spindle checkpoint function ahead of facilitation of cell proliferation by repeated administration of hepatocarcinogens in rats.","authors":"M. Kimura, S. Mizukami, Yousuke Watanabe, Yasuko Hasegawa-Baba, N. Onda, Toshinori Yoshida, M. Shibutani","doi":"10.2131/jts.40.855","DOIUrl":null,"url":null,"abstract":"We aimed to clarify the hepatocarcinogen-specific disruption of cell cycle checkpoint functions and its time course after repeated administration of hepatocarcinogens. Thus, rats were repeatedly administered with hepatocarcinogens (methapyrilene, carbadox and thioacetamide), a marginal hepatocarcinogen (leucomalachite green), hepatocarcinogenic promoters (oxfendazole and β-naphthoflavone) or non-carcinogenic hepatotoxicants (promethazine and acetaminophen) for 7, 28 or 90 days, and the temporal changes in cell proliferation, expression of G1/S and spindle checkpoint-related molecules, and apoptosis were examined using immunohistochemistry and/or real-time RT-PCR analysis. Hepatocarcinogens facilitating cell proliferation at day 28 of administration also facilitated cell proliferation and apoptosis at day 90. Hepatocarcinogen- or hepatocarcinogenic promoter-specific cellular responses were not detected by immunohistochemical single molecule analysis even after 90 days. Expression of Cdkn1a, Mad2l1, Chek1 and Rbl2 mRNA also lacked specificity to hepatocarcinogens or hepatocarcinogenic promoters. In contrast, all hepatocarcinogens and the marginally hepatocarcinogenic leucomalachite green induced Mdm2 upregulation or increase in the number of phosphorylated MDM2(+) cells from day 28, irrespective of the lack of cell proliferation facilitation by some compounds. However, different Tp53 expression levels suggest different mechanisms of induction or activation of MDM2 among hepatocarcinogens. On the other hand, hepatocarcinogenic methapyrilene and carbadox downregulated the number of both ubiquitin D(+) cells and proliferating cells remaining in M phase at day 28 and/or day 90, irrespective of the lack of cell proliferation facilitation in the latter. These results suggest that hepatocarcinogens disrupt spindle checkpoint function after 28 or 90 days of administration, which may be induced ahead of cell proliferation facilitation.","PeriodicalId":231048,"journal":{"name":"The Journal of toxicological sciences","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of toxicological sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2131/jts.40.855","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

We aimed to clarify the hepatocarcinogen-specific disruption of cell cycle checkpoint functions and its time course after repeated administration of hepatocarcinogens. Thus, rats were repeatedly administered with hepatocarcinogens (methapyrilene, carbadox and thioacetamide), a marginal hepatocarcinogen (leucomalachite green), hepatocarcinogenic promoters (oxfendazole and β-naphthoflavone) or non-carcinogenic hepatotoxicants (promethazine and acetaminophen) for 7, 28 or 90 days, and the temporal changes in cell proliferation, expression of G1/S and spindle checkpoint-related molecules, and apoptosis were examined using immunohistochemistry and/or real-time RT-PCR analysis. Hepatocarcinogens facilitating cell proliferation at day 28 of administration also facilitated cell proliferation and apoptosis at day 90. Hepatocarcinogen- or hepatocarcinogenic promoter-specific cellular responses were not detected by immunohistochemical single molecule analysis even after 90 days. Expression of Cdkn1a, Mad2l1, Chek1 and Rbl2 mRNA also lacked specificity to hepatocarcinogens or hepatocarcinogenic promoters. In contrast, all hepatocarcinogens and the marginally hepatocarcinogenic leucomalachite green induced Mdm2 upregulation or increase in the number of phosphorylated MDM2(+) cells from day 28, irrespective of the lack of cell proliferation facilitation by some compounds. However, different Tp53 expression levels suggest different mechanisms of induction or activation of MDM2 among hepatocarcinogens. On the other hand, hepatocarcinogenic methapyrilene and carbadox downregulated the number of both ubiquitin D(+) cells and proliferating cells remaining in M phase at day 28 and/or day 90, irrespective of the lack of cell proliferation facilitation in the latter. These results suggest that hepatocarcinogens disrupt spindle checkpoint function after 28 or 90 days of administration, which may be induced ahead of cell proliferation facilitation.
反复给药肝致癌物在促进大鼠细胞增殖之前破坏梭形检查点功能。
我们的目的是阐明肝癌致癌物对细胞周期检查点功能的特异性破坏及其在反复使用肝癌致癌物后的时间过程。因此,大鼠在7、28或90天内反复给予肝癌致癌物(甲基吡啶、卡多克斯和硫代乙酰胺)、边缘肝癌致癌物(白孔雀石绿)、肝癌促进剂(奥芬唑和β-萘黄酮)或非致癌物(异丙嗪和对乙酰氨基酚),观察细胞增殖、G1/S表达和纺锤体检查点相关分子的时间变化。采用免疫组织化学和/或实时RT-PCR分析检测细胞凋亡。在给药第28天促进细胞增殖的肝癌物质在第90天也促进细胞增殖和凋亡。即使在90天后,免疫组织化学单分子分析也未检测到肝癌或肝癌启动子特异性细胞反应。Cdkn1a、Mad2l1、Chek1和Rbl2 mRNA的表达也对肝癌致癌物或肝癌启动子缺乏特异性。相比之下,所有肝癌致癌物和轻度肝癌致癌物白垩绿诱导Mdm2上调或增加磷酸化Mdm2(+)细胞的数量,而不考虑某些化合物缺乏细胞增殖促进作用。然而,不同的Tp53表达水平提示不同肝癌致癌物诱导或激活MDM2的机制不同。另一方面,在第28天和/或第90天,肝癌致癌性甲基嘧啶和卡多克斯下调泛素D(+)细胞和处于M期的增殖细胞的数量,而不考虑后者缺乏细胞增殖促进。这些结果表明,肝癌致癌物在给药28或90天后会破坏纺锤体检查点功能,这可能是在促进细胞增殖之前诱导的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信